Anthony D'Adamio
CIK: 0001835184
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bioventus Inc.
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Apr 10, 2026BVS
Bioventus Inc.
Exercise(M)Direct9.9K shares- - Apr 10, 2026BVS
Bioventus Inc.
Tax Payment(F)Direct4.3K shares at avg. $9.06$39K - Mar 13, 2026BVS
Bioventus Inc.
Award(A)DirectStock Option (Right to Buy)
92K shares- - Mar 13, 2026BVS
Bioventus Inc.
Exercise(M)Direct8.9K shares- - Mar 13, 2026BVS
Bioventus Inc.
Tax Payment(F)Direct3.9K shares at avg. $8.62$33K - Mar 13, 2026BVS
Bioventus Inc.
Exercise(M)Direct8.8K shares- - Mar 13, 2026BVS
Bioventus Inc.
Tax Payment(F)Direct3.8K shares at avg. $8.62$33K - Mar 13, 2026BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
83K shares- - Feb 15, 2026BVS
Bioventus Inc.
Exercise(M)Direct13K shares- - Feb 15, 2026BVS
Bioventus Inc.
Tax Payment(F)Direct6.3K shares at avg. $8.27$52K - Apr 11, 2025BVS
Bioventus Inc.
Sale(S)Direct3K shares at avg. $7.57$22K - Apr 10, 2025BVS
Bioventus Inc.
Exercise(M)Direct9.9K shares- - Mar 17, 2025BVS
Bioventus Inc.
Sale(S)Direct2.6K shares at avg. $9.75$25K - Mar 14, 2025BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
35K shares- - Mar 14, 2025BVS
Bioventus Inc.
Award(A)DirectStock Option (Right to Buy)
40K shares- - Mar 14, 2025BVS
Bioventus Inc.
Exercise(M)Direct8.9K shares- - Feb 18, 2025BVS
Bioventus Inc.
Sale(S)Direct4.4K shares at avg. $10.19$45K - Feb 15, 2025BVS
Bioventus Inc.
Exercise(M)Direct13K shares- - Dec 23, 2024BVS
Bioventus Inc.
Sale(S)Direct5.8K shares at avg. $10.53$62K - Dec 20, 2024BVS
Bioventus Inc.
Exercise(M)Direct19.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 10, 2026 | BVS Bioventus Inc. | Exercise(M) | 9,925 | - | $0 | Direct |
| Apr 10, 2026 | BVS Bioventus Inc. | Tax Payment(F) | 4,312 | $9.06 | $39,067 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Award(A) Stock Option (Right to Buy) | 92,000 | - | - | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Exercise(M) | 8,886 | - | $0 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Tax Payment(F) | 3,861 | $8.62 | $33,282 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Exercise(M) | 8,750 | - | $0 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Tax Payment(F) | 3,802 | $8.62 | $32,773 | Direct |
| Mar 13, 2026 | BVS Bioventus Inc. | Award(A) Restricted Stock Units | 83,000 | - | - | Direct |
| Feb 15, 2026 | BVS Bioventus Inc. | Exercise(M) | 12,980 | - | $0 | Direct |
| Feb 15, 2026 | BVS Bioventus Inc. | Tax Payment(F) | 6,327 | $8.27 | $52,324 | Direct |
| Apr 11, 2025 | BVS Bioventus Inc. | Sale(S) | 2,958 | $7.57 | $22,392 | Direct |
| Apr 10, 2025 | BVS Bioventus Inc. | Exercise(M) | 9,925 | - | - | Direct |
| Mar 17, 2025 | BVS Bioventus Inc. | Sale(S) | 2,615 | $9.75 | $25,496 | Direct |
| Mar 14, 2025 | BVS Bioventus Inc. | Award(A) Restricted Stock Units | 35,000 | - | - | Direct |
| Mar 14, 2025 | BVS Bioventus Inc. | Award(A) Stock Option (Right to Buy) | 40,000 | - | - | Direct |
| Mar 14, 2025 | BVS Bioventus Inc. | Exercise(M) | 8,886 | - | - | Direct |
| Feb 18, 2025 | BVS Bioventus Inc. | Sale(S) | 4,380 | $10.19 | $44,632 | Direct |
| Feb 15, 2025 | BVS Bioventus Inc. | Exercise(M) | 12,980 | - | - | Direct |
| Dec 23, 2024 | BVS Bioventus Inc. | Sale(S) | 5,848 | $10.53 | $61,579 | Direct |
| Dec 20, 2024 | BVS Bioventus Inc. | Exercise(M) | 19,850 | - | $0 | Direct |
1-20 of 20 transactions
About D'Adamio Anthony
D'Adamio Anthony (SEC CIK 0001835184) files insider reports with the SEC as SVP & General Counsel of Bioventus Inc. (BVS).
Signal8 holds 11 ownership filings by D'Adamio Anthony, all Form 4s, filed between Dec 23, 2024 and Apr 14, 2026. Those filings report 20 transactions, from Dec 20, 2024 to Apr 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on D'Adamio Anthony's filings is in DURHAM, NC.
Recent filings by D'Adamio Anthony
- Apr 10, 2026: Option exercise of BVS shares (Form 4, code M).
- Apr 10, 2026: Tax withholding of BVS shares (Form 4, code F).
- Mar 13, 2026: Grant or award of BVS derivative securities (Form 4, code A).
- Mar 13, 2026: Option exercise of BVS shares (Form 4, code M).
- Mar 13, 2026: Tax withholding of BVS shares (Form 4, code F).
Other insiders filing for Bioventus Inc. (BVS)
- Bartholdson John A., Director
- SUTTER MARTIN P, Director
- STALNECKER SUSAN M, Director
- NOHRA GUY P, Director
- NEELS GUIDO J, Director
- McMurry-Heath Michelle, Director